Clinical Trial: Intravenous Iron in the Management of Drug-resistant Restless Legs syndromeI

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822607) titled 'Intravenous Iron in the Management of Drug-resistant Restless Legs syndromeI' on Aug. 28.

Brief Summary: The pathophysiology of restless legs syndrome (RLS) is not well understood: it is thought to involve intracerebral iron deficiency and dopaminergic dysregulation.

This study aims to evaluate the use of intravenous ferric carboxymaltose in patients with restless legs syndrome (RLS).

This study plans to include individuals with RLS, who will be divided into two groups:

* One group will receive intravenous iron immediately after the baseline polysomnography

* The second group will receive intravenous iron 3 months after randomi...